SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics is trending after announcing a proposed non-binding business combination with Applied Digital's cloud computing division to form ChronoScale, an AI-focused GPU compute platform. This strategic pivot into the booming AI infrastructure sector has ignited fervent community discussion, with many anticipating significant upside and a short squeeze. Conversely, some investors are expressing caution regarding potential dilution and the existing shareholders' anticipated smaller stake in the new entity.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is gaining significant attention following a new eight-figure contract to provide spacecraft docking systems for a European space capsule, igniting discussions among investors. The community is actively highlighting the company's perceived undervaluation, short squeeze potential, and strategic position within the burgeoning space and defense sectors. Many anticipate substantial growth from Redwire's diverse portfolio, including space infrastructure, microgravity development, and advanced drone technologies, with some aggressively buying dips in expectation of future catalysts and sector-wide expansion.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending amidst intense investor frustration over prolonged management silence regarding potential partnerships for its critical combined flu/COVID vaccine. Community discussion is dominated by calls for CEO John Jacobs' removal and speculation that the quiet signals imminent major deals or a potential buyout, especially given the company's protein-based platform and activist pressure from Shah Capital.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is a hot topic, with many anticipating significant announcements at the upcoming CES 2026 and noting recent analyst upgrades. While bulls highlight strong underlying technology and robust financials, persistent insider selling and prolonged price declines are major concerns for skeptics. The community is actively discussing potential new partnerships and a rebound as year-end tax-loss selling concludes.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending due to high anticipation for its upcoming CES 2026 programming, where it will showcase advancements in AI-powered marketing and its Athena platform, fueling community speculation around potential catalysts. Investors largely view the MarTech innovator as significantly undervalued, anticipating a major re-rating driven by strong fundamentals and its leadership in AI-driven customer intelligence.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is actively trending amid significant buzz around its AI initiatives, particularly its Kunlunxin chip division reportedly replacing Nvidia hardware for Deepseek's inference and exploring a Hong Kong IPO. The community is eagerly discussing the considerable undervaluation of Baidu's Apollo Go autonomous driving unit compared to global peers, fueled by a recent major analyst upgrade highlighting strong growth potential in AI and cloud services.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending due to a Reuters report suggesting Nvidia halted testing of its 18A chip process, sparking debate on whether this is a legitimate setback or a "hit piece" to manipulate the stock. The community is highlighting Nvidia's recent $5 billion equity investment and Intel's critical role as the leading US-based advanced chip manufacturer, anticipating future catalysts like CES and foundry customer announcements to drive substantial growth.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind is trending due to recent regulatory progress for its FUROSCIX ReadyFlow autoinjector and ongoing discussions about the Afrezza launch in India. While optimism surrounds the autoinjector's potential to significantly impact the edema market and the continued success of its partnership with United Therapeutics, community sentiment is divided on Afrezza's international prospects, and the company's leadership remains a point of contention among investors.

FTAI Aviation Ltd. focuses on owning, leasing, and servicing commercial jet engines, with a primary focus on CFM56 and V2500 engines. Its portfolio of products, including the Module Factory and a joint venture to manufacture engine PMA components, enables cost savings and flexibility for its airline, lessor, and MRO customer base. The company operates through two segments: Aviation Leasing and Aerospace Products. The Aviation Leasing segment owns and manages aviation assets, including aircraft and engines, which it leases and sells to customers. The Aerospace Products segment develops, manufactures, repairs/refurbishes, and sells aircraft engines and aftermarket components for the CFM56-7B, CFM56-5B, and V2500 engines through its maintenance facilities, equity method investments, and exclusivity arrangements. FTAI Aviation is headquartered in New York, NY.

FTAI Aviation Ltd - Ordinary Shares - Class A

FTAI Aviation Ltd

FTAI Aviation is trending as its audit committee declared previous short seller allegations "without merit," coinciding with strong earnings results and an increased dividend. The community is actively discussing the company's strategic capital initiatives and its role in converting aircraft engines for AI data center energy supply, with many anticipating continued growth and a potential short squeeze after recent analyst upgrades.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is highly active amid strong Phase 3 data for relacorilant in platinum-resistant ovarian cancer, touted by many as a potential new standard of care and multi-billion-dollar opportunity. This pivotal news, coupled with encouraging survival data for its ALS program and an upcoming FDA decision for Cushing Syndrome, has intensified community discussions around the stock's underlying value and the potential for a massive short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$COUV have we historical reoccurring filings around the new year? Could narrow down when we&#39;re expecting news.

deb Garbutt

btown_moneymike

Tim W Paul

StockTwits For Android 

Corporate Universe Inc

 have we historical reoccurring filings around the new year? Could narrow down when we're expecting news.

QNTpiranha

FarmerTrader

JoshEngland

@QNTpiranha let&#39;s hope caveat emptor gets lifted and we can trade on the open market again.

StockTwits Web

 let's hope caveat emptor gets lifted and we can trade on the open market again.